$GIFX: SEC filings imminent per CEO Tweet today ! Thurs

New Post Public Reply Private Reply Replies (0) Message Board
Dspeer
671
$GIFX: SEC filings imminent per CEO Tweet today !

Thurs July 18, 2019

An OTC Play with Revenues, Earnings and Assets..it's big...huge...

Anything stated here to the contrary is pure disinformation, stockbullshit, false narratives and not based in fact or reality.

A highly coordinated effort has been mounted by a short firm to try and discredit this stock and company, we know who they are now, down to the minutia, every detail. Investigators have them 100% positively identified.



Our on-ground due diligence and people who have seen it up close, of course knew all this already (and yes, we have multi-lingual folks so we don't need Google translate, and we can call the company or any subsidiary by phone and speak to them, etc to verify our rock solid due diligence, as opposed to the highly coordinated short firm disinformation and false narrative campaign being propagated daily to try and harm the company and the stock).

The coordinated short firm efforts at disinformation and grossly false narratives will have no effect on what is about to take place here with this huge GIFX reverse merger, none. None at all. It's over for them and the highly coordinated and orchestrated non stop disinformation campaign.

GIFA, they built a $12 million euro new world headquarters, and did it in approx 4 short months, from start to finish. We've had people visit inside the building- it's state of the art, and absolutely immaculate and stunning (marble, fine hardwoods, state of the art computing running a central server to distributed workstations they have so many employees, etc)

The main Grandex Finance location (there will be branches) - it's in a newly built, immaculate and up-scale outdoor shopping mall and promenade. Trendy brand name fashion shops, dining and cafes, and other posh businesses on entire block. Businesses on bottom, professional offices for doctors and attorneys etc on 2nd floor, and trendy Euro-style loft apartments above. It's a beautiful location - and as usual, Kisa's facility is immaculate inside and out, like the headquarters building. Very high-end area of town, Grandex Finance. We have "on the ground" extensive photos and video.

This is not a standard vapor-ware OTC reverse merger. The company has many employees, they have revenues and profits as the CEO pointed out today in preparing their final reverse merger SEC filings and balance sheets, they have hard assets like real estate, they're a real business and have real assets.

This is easily a $1 dollar per share stock just to start off with. It will only get better from there as they roll-in all their final business subsidiary units by end of 2019.

They have the share structure of a NASDAQ company:

160 million shares outstanding (a pittance)

47 million share micro float, almost unheard of on the OTC

Zero dilution, none. Not a single share ever diluted since Gifa took-over and began the reverse merger - unheard of in OTC-ville. And 100% contrary to the false narratives and coordinated disinformation campaign of the short firm and those propagating false narratives.

Gifa operate a major finance/loan brokering division, they purchased Grandex Finance which does "factoring loans" to small and mid-sized businesses, an extremely lucrative sector to be in, and they do pay-day style personal loans from Grandex also.

They have a tourism division and operate other branch services such as a call center, etc. They own and operate a Forex trading desk as part of their financial sector businesses, etc.

A true conglomerate and growing - with plans already moving ahead to buy a pharmaceutical company Intel Chemicals (raw materials and some finished drugs) - and we have "on the ground" photos of that facility already also - and have contact with them via telephone in their native language, it's very real, and very proven to be factual. Yes.

http://intelchemicals.com/

This is going to be a spectacular reverse merger play- this is the ground floor here. When they cut loose the SEC filings, it's going to move at epic speeds given the micro float. Light speeds.

It's already proven GIFX stock can move 25% or more on a lousy $2 or $3K of buying on low volume. When they SEC file, this will trade almost the entire float in a matter of a day or two- it can move 50% to 100% in a single day, easily, again due to the micro float and majority of that float already held by longs (yes, we have a good idea how much of the float is already held by longs, a majority portion, it's verified due diligence).

The facts below, this is what this mega reverse merger is all about. No OTC "alternative filer" nonsense here. Full SEC filer only - expect a SEC FORM 10, and then a series of 10-Q's for the remaining 2 quarters, a few misc SEC filings and they will instantly be "SEC CURRENT", the CE mark will vanish, and the chase will be epic, one for the record books IMO:



Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.

Gifa, Inc. (GIFX) Stock Research Links

GIFX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

WeightWatchers Shifts 2025 Earnings Call for Key Accounting Updates

Updated Category News Views 154

WeightWatchers Adjusts Schedule for 2025 Earnings Report WW International, Inc. (NASDAQ: WW), widely recognized for its innovative weight management solutions, has made an important change regarding its upcoming earnings report. The company has rescheduled its earnings release and associated conference call originally intended for August 5, 2025. This Rescheduling is...

Continue Reading
Investors Alert: Key Investigations into Regeneron Pharmaceuticals

Updated Category News Views 120

Investors Take Note: Faruqi & Faruqi Seeks to Help Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is leading an investigation focusing on investors who may have sustained significant losses with Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). The firm encourages those who believe they have suffered losses of over $100,000 due to the company’s...

Continue Reading
Waller's Bold Critique of Powell: A Call for Rate Cuts

Updated Category News Views 233

Waller’s Challenge to Economic Caution Federal Reserve Governor Christopher Waller has made headlines by challenging the stance of Chairman Jerome Powell, particularly regarding his assertion that economic data is too sparse to draw clear conclusions. Waller believes the Fed should proceed with easing monetary policy, even amidst perceived gaps in information. Ending...

Continue Reading
Michael John Politis Recognized as Elite Attorney in America

Updated Category News Views 276

Michael John Politis Achieves National Recognition Michael John Politis, a distinguished attorney at Politis & Matovina, P.A., has garnered significant acclaim by being recognized as a member of the Nation's Top One Percent. This prestigious acknowledgment is bestowed by the National Association of Distinguished Counsel (NADC). The NADC is committed to upholding the...

Continue Reading
Home Buying Opportunities: Navigating the Market's Shift

Updated Category News Views 74

Introduction For many home buyers, fall typically signals a slow down in the housing market. But this year, things might unfold differently. With mortgage rates dropping and inventory on the rise, buyers could have a chance to find their dream homes during what is usually seen as the offseason. Affordability Improves The recent decline in monthly mortgage payments has...

Continue Reading